Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Cell Rep ; 42(6): 112554, 2023 06 27.
Article in English | MEDLINE | ID: mdl-37235473

ABSTRACT

Intracortical microstimulation (ICMS) enables applications ranging from neuroprosthetics to causal circuit manipulations. However, the resolution, efficacy, and chronic stability of neuromodulation are often compromised by adverse tissue responses to the indwelling electrodes. Here we engineer ultraflexible stim-nanoelectronic threads (StimNETs) and demonstrate low activation threshold, high resolution, and chronically stable ICMS in awake, behaving mouse models. In vivo two-photon imaging reveals that StimNETs remain seamlessly integrated with the nervous tissue throughout chronic stimulation periods and elicit stable, focal neuronal activation at low currents of 2 µA. Importantly, StimNETs evoke longitudinally stable behavioral responses for over 8 months at a markedly low charge injection of 0.25 nC/phase. Quantified histological analyses show that chronic ICMS by StimNETs induces no neuronal degeneration or glial scarring. These results suggest that tissue-integrated electrodes provide a path for robust, long-lasting, spatially selective neuromodulation at low currents, which lessens risk of tissue damage or exacerbation of off-target side effects.


Subject(s)
Somatosensory Cortex , Mice , Animals , Somatosensory Cortex/physiology , Electrodes , Electric Stimulation/methods , Electrodes, Implanted
2.
bioRxiv ; 2023 Feb 21.
Article in English | MEDLINE | ID: mdl-36865195

ABSTRACT

Intracortical microstimulation (ICMS) enables applications ranging from neuroprosthetics to causal circuit manipulations. However, the resolution, efficacy, and chronic stability of neuromodulation is often compromised by the adverse tissue responses to the indwelling electrodes. Here we engineer ultraflexible stim-Nanoelectronic Threads (StimNETs) and demonstrate low activation threshold, high resolution, and chronically stable ICMS in awake, behaving mouse models. In vivo two-photon imaging reveals that StimNETs remain seamlessly integrated with the nervous tissue throughout chronic stimulation periods and elicit stable, focal neuronal activation at low currents of 2 µA. Importantly, StimNETs evoke longitudinally stable behavioral responses for over eight months at markedly low charge injection of 0.25 nC/phase. Quantified histological analysis show that chronic ICMS by StimNETs induce no neuronal degeneration or glial scarring. These results suggest that tissue-integrated electrodes provide a path for robust, long-lasting, spatially-selective neuromodulation at low currents which lessen risks of tissue damage or exacerbation of off-target side-effects.

3.
Sci Rep ; 8(1): 13715, 2018 Sep 07.
Article in English | MEDLINE | ID: mdl-30194313

ABSTRACT

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

4.
Sci Rep ; 8(1): 10562, 2018 Jul 12.
Article in English | MEDLINE | ID: mdl-30002493

ABSTRACT

Accumulating evidence supports the role of astrocytes in endocannabinoid mediated modulation of neural activity. It has been reported that some astrocytes express the cannabinoid type 1 receptor (CB1-R), the activation of which is leading to Ca2+ mobilization from internal stores and a consecutive release of glutamate. It has also been documented that astrocytes have the potential to produce the endocannabinoid 2-arachidonoylglycerol, one of the best known CB1-R agonist. However, no relationship between CB1-R activation and 2-arachidonoylglycerol production has ever been demonstrated. Here we show that rat spinal astrocytes co-express CB1-Rs and the 2-arachidonoylglycerol synthesizing enzyme, diacylglycerol lipase-alpha in close vicinity to each other. We also demonstrate that activation of CB1-Rs induces a substantial elevation of intracellular Ca2+ concentration in astrocytes. Finally, we provide evidence that the evoked Ca2+ transients lead to the production of 2-arachidonoylglycerol in cultured astrocytes. The results provide evidence for a novel cannabinoid induced endocannabinoid release mechanism in astrocytes which broadens the bidirectional signaling repertoire between astrocytes and neurons.


Subject(s)
Arachidonic Acids/metabolism , Astrocytes/metabolism , Calcium/metabolism , Endocannabinoids/metabolism , Glycerides/metabolism , Receptor, Cannabinoid, CB1/metabolism , Animals , Cell Communication , Cells, Cultured , Lipoprotein Lipase/metabolism , Mice, Inbred C57BL , Mice, Knockout , Neurons/metabolism , Primary Cell Culture , Rats , Rats, Inbred WKY , Receptor, Cannabinoid, CB1/genetics , Spinal Cord Dorsal Horn/cytology , Spinal Cord Dorsal Horn/metabolism
5.
Front Cell Neurosci ; 12: 105, 2018.
Article in English | MEDLINE | ID: mdl-29731709

ABSTRACT

The orbitofrontal cortex (OFC) has been implicated in a multiplicity of complex brain functions, including representations of expected outcome properties, post-decision confidence, momentary food-reward values, complex flavors and odors. As breathing rhythm has an influence on odor processing at primary olfactory areas, we tested the hypothesis that it may also influence neuronal activity in the OFC, a prefrontal area involved also in higher order processing of odors. We recorded spike timing of orbitofrontal neurons as well as local field potentials (LFPs) in awake, head-fixed mice, together with the breathing rhythm. We observed that a large majority of orbitofrontal neurons showed robust phase-coupling to breathing during immobility and running. The phase coupling of action potentials to breathing was significantly stronger in orbitofrontal neurons compared to cells in the medial prefrontal cortex. The characteristic synchronization of orbitofrontal neurons with breathing might provide a temporal framework for multi-variable processing of olfactory, gustatory and reward-value relationships.

6.
J Neurosci ; 37(39): 9534-9549, 2017 09 27.
Article in English | MEDLINE | ID: mdl-28874448

ABSTRACT

The basal forebrain (BF) receives afferents from brainstem ascending pathways, which has been implicated first by Moruzzi and Magoun (1949) to induce forebrain activation and cortical arousal/waking behavior; however, it is very little known about how brainstem inhibitory inputs affect cholinergic functions. In the current study, glycine, a major inhibitory neurotransmitter of brainstem neurons, and gliotransmitter of local glial cells, was tested for potential interaction with BF cholinergic (BFC) neurons in male mice. In the BF, glycine receptor α subunit-immunoreactive (IR) sites were localized in choline acetyltransferase (ChAT)-IR neurons. The effect of glycine on BFC neurons was demonstrated by bicuculline-resistant, strychnine-sensitive spontaneous IPSCs (sIPSCs; 0.81 ± 0.25 × 10-1 Hz) recorded in whole-cell conditions. Potential neuronal as well as glial sources of glycine were indicated in the extracellular space of cholinergic neurons by glycine transporter type 1 (GLYT1)- and GLYT2-IR processes found in apposition to ChAT-IR cells. Ultrastructural analyses identified synapses of GLYT2-positive axon terminals on ChAT-IR neurons, as well as GLYT1-positive astroglial processes, which were localized in the vicinity of synapses of ChAT-IR neurons. The brainstem raphe magnus was determined to be a major source of glycinergic axons traced retrogradely from the BF. Our results indicate a direct effect of glycine on BFC neurons. Furthermore, the presence of high levels of plasma membrane glycine transporters in the vicinity of cholinergic neurons suggests a tight control of extracellular glycine in the BF.SIGNIFICANCE STATEMENT Basal forebrain cholinergic (BFC) neurons receive various activating inputs from specific brainstem areas and channel this information to the cortex via multiple projections. So far, very little is known about inhibitory brainstem afferents to the BF. The current study established glycine as a major regulator of BFC neurons by (1) identifying glycinergic neurons in the brainstem projecting to the BF, (2) showing glycine receptor α subunit-immunoreactive (IR) sites in choline acetyltransferase (ChAT)-IR neurons, (3) demonstrating glycine transporter type 2 (GLYT2)-positive axon terminals synapsing on ChAT-IR neurons, and (4) localizing GLYT1-positive astroglial processes in the vicinity of synapses of ChAT-IR neurons. The effect of glycine on BFC neurons was demonstrated by bicuculline-resistant, strychnine-sensitive spontaneous IPSCs recorded in whole-cell conditions.


Subject(s)
Cholinergic Neurons/metabolism , Glycine/metabolism , Prosencephalon/metabolism , Animals , Bicuculline/pharmacology , Choline O-Acetyltransferase/genetics , Choline O-Acetyltransferase/metabolism , Cholinergic Neurons/drug effects , Cholinergic Neurons/physiology , Female , Glycine/pharmacology , Glycine Agents/pharmacology , Glycine Plasma Membrane Transport Proteins/genetics , Glycine Plasma Membrane Transport Proteins/metabolism , Inhibitory Postsynaptic Potentials , Male , Mice , Neuroglia/metabolism , Prosencephalon/cytology , Strychnine/pharmacology , Synapses/drug effects , Synapses/metabolism , Synapses/physiology
7.
Stem Cells ; 33(3): 726-41, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25388207

ABSTRACT

Retinoids are morphogens and have been implicated in cell fate commitment of embryonic stem cells (ESCs) to neurons. Their effects are mediated by RAR and RXR nuclear receptors. However, transcriptional cofactors required for cell and gene-specific retinoid signaling are not known. Here we show that protein arginine methyl transferase (PRMT) 1 and 8 have key roles in determining retinoid regulated gene expression and cellular specification in a multistage neuronal differentiation model of murine ESCs. PRMT1 acts as a selective modulator, providing the cells with a mechanism to reduce the potency of retinoid signals on regulatory "hotspots." PRMT8 is a retinoid receptor target gene itself and acts as a cell type specific transcriptional coactivator of retinoid signaling at later stages of differentiation. Lack of either of them leads to reduced nuclear arginine methylation, dysregulated neuronal gene expression, and altered neuronal activity. Importantly, depletion of PRMT8 results in altered expression of a distinct set of genes, including markers of gliomagenesis. PRMT8 is almost entirely absent in human glioblastoma tissues. We propose that PRMT1 and PRMT8 serve as a rheostat of retinoid signaling to determine neuronal cell specification in a context-dependent manner and might also be relevant in the development of human brain malignancy.


Subject(s)
Embryonic Stem Cells/cytology , Neurons/cytology , Protein-Arginine N-Methyltransferases/metabolism , Receptors, Retinoic Acid/metabolism , Animals , Cell Differentiation/physiology , Cell Line, Tumor , Embryonic Stem Cells/enzymology , Embryonic Stem Cells/metabolism , Gene Expression , Glioblastoma , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Neurons/enzymology , Neurons/metabolism , Protein-Arginine N-Methyltransferases/genetics , Repressor Proteins/genetics , Repressor Proteins/metabolism , Signal Transduction
8.
Brain Struct Funct ; 220(5): 3023-41, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25009314

ABSTRACT

The pedunculopontine nucleus (PPN) is known as the cholinergic part of the reticular activating system (RAS) and it plays an important role in transitions of slow-wave sleep to REM sleep and wakefulness. Although both exogenous and endocannabinoids affect sleep, the mechanism of endocannabinoid neuromodulation has not been characterized at cellular level in the PPN. In this paper, we demonstrate that both neurons and glial cells from the PPN respond to cannabinoid type 1 (CB1) receptor agonists. The neuronal response can be depolarization or hyperpolarization, while astrocytes exhibit more frequent calcium waves. All these effects are absent in CB1 gene-deficient mice. Blockade of the fast synaptic neurotransmission or neuronal action potential firing does not change the effect on the neuronal membrane potential significantly, while inhibition of astrocytic calcium waves by thapsigargin diminishes the response. Inhibition of group I metabotropic glutamate receptors (mGluRs) abolishes hyperpolarization, whereas blockade of group II mGluRs prevents depolarization. Initially active neurons and glial cells display weaker responses partially due to the increased endocannabinoid tone in their environment. Taken together, we propose that cannabinoid receptor stimulation modulates PPN neuronal activity in the following manner: active neurons may elicit calcium waves in astrocytes via endogenous CB1 receptor agonists. Astrocytes in turn release glutamate that activates different metabotropic glutamate receptors of neurons and modulate PPN neuronal activity.


Subject(s)
Astrocytes/cytology , Endocannabinoids/metabolism , Membrane Potentials/physiology , Neurons/metabolism , Pedunculopontine Tegmental Nucleus/metabolism , Animals , Brain Stem/metabolism , Glutamic Acid/metabolism , Mice , Receptors, Metabotropic Glutamate/metabolism , Synaptic Transmission/physiology
9.
Eur J Neurosci ; 37(6): 876-90, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23301797

ABSTRACT

Giant cells of the cochlear nucleus are thought to integrate multimodal sensory inputs and participate in monaural sound source localization. Our aim was to explore the significance of a hyperpolarization-activated current in determining the activity of giant neurones in slices prepared from 10 to 14-day-old rats. When subjected to hyperpolarizing stimuli, giant cells produced a 4-(N-ethyl-N-phenylamino)-1,2-dimethyl-6-(methylamino) pyridinium chloride (ZD7288)-sensitive inward current with a reversal potential and half-activation voltage of -36 and -88 mV, respectively. Consequently, the current was identified as the hyperpolarization-activated non-specific cationic current (Ih ). At the resting membrane potential, 3.5% of the maximum Ih conductance was available. Immunohistochemistry experiments suggested that hyperpolarization-activated, cyclic nucleotide-gated, cation non-selective (HCN)1, HCN2, and HCN4 subunits contribute to the assembly of the functional channels. Inhibition of Ih hyperpolarized the membrane by 6 mV and impeded spontaneous firing. The frequencies of spontaneous inhibitory and excitatory postsynaptic currents reaching the giant cell bodies were reduced but no significant change was observed when evoked postsynaptic currents were recorded. Giant cells are affected by biphasic postsynaptic currents consisting of an excitatory and a subsequent inhibitory component. Inhibition of Ih reduced the frequency of these biphasic events by 65% and increased the decay time constants of the inhibitory component. We conclude that Ih adjusts the resting membrane potential, contributes to spontaneous action potential firing, and may participate in the dendritic integration of the synaptic inputs of the giant neurones. Because its amplitude was higher in young than in adult rats, Ih of the giant cells may be especially important during the postnatal maturation of the auditory system.


Subject(s)
Cochlear Nucleus/physiology , Giant Cells/physiology , Ion Transport , Membrane Potentials , Neurons/physiology , Animals , Cations/metabolism , Cell Membrane/physiology , Cochlear Nucleus/cytology , Cyclic Nucleotide-Gated Cation Channels/antagonists & inhibitors , Cyclic Nucleotide-Gated Cation Channels/metabolism , Excitatory Postsynaptic Potentials , Giant Cells/metabolism , Inhibitory Postsynaptic Potentials , Neurons/metabolism , Protein Multimerization , Protein Subunits/antagonists & inhibitors , Protein Subunits/metabolism , Pyrimidines/pharmacology , Rats , Rats, Wistar
10.
Brain Struct Funct ; 218(5): 1279-92, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23052547

ABSTRACT

Correct interpretation of functional data obtained from various cell types of the cochlear nucleus (CN), a structure involved in auditory information processing, necessitates reliable cell identification. Our aim was to perform a quantitative morphological characterization of giant and pyramidal cells of the rat CN and identify parameters that are suitable for their adequate classification. Neurons were labeled with biocytin, visualized with a fluorescent marker, and three-dimensionally reconstructed from confocal images. The size and shape of the soma and dendritic tree of each neuron were characterized by 17 morphometric parameters. The variables were subjected to multivariate statistical analysis to determine their importance while discriminating between giant and pyramidal cells. Our results provide a new battery of morphometric data, which could not be obtained earlier, improve the chances of correct cell identification, make modeling experiments easier and more reliable, and help us to understand both the functions of individual CN neurons and the network properties of this nucleus. In addition, we demonstrate that even partial labeling and/or incomplete reconstruction of neurons may be enough for their correct identification if selected parameters describing the cell bodies and the proximal portions of the dendritic trees are utilized. We propose that our findings have specific relevance to studies which attempt cell identification after functional experiments resulting in incomplete labeling of the investigated neurons.


Subject(s)
Cochlear Nucleus/cytology , Pyramidal Cells/cytology , Animals , Cell Size , Fluorescence , Imaging, Three-Dimensional , Lysine/analogs & derivatives , Microscopy, Confocal , Multivariate Analysis , Rats
11.
J Neurochem ; 123(1): 84-99, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22817114

ABSTRACT

Protein phosphatase-1M (PP1M, myosin phosphatase) consists of a PP1 catalytic subunit (PP1c) and the myosin phosphatase target subunit-1 (MYPT1). RhoA-activated kinase (ROK) regulates PP1M via inhibitory phosphorylation of MYPT1. Using multidisciplinary approaches, we have studied the roles of PP1M and ROK in neurotransmission. Electron microscopy demonstrated the presence of MYPT1 and ROK in both pre- and post-synaptic terminals. Tautomycetin (TMC), a PP1-specific inhibitor, decreased the depolarization-induced exocytosis from cortical synaptosomes. trans-4-[(1R)-1-aminoethyl]-N-4-pyridinylcyclohexanecarboxamide dihydrochloride, a ROK-specific inhibitor, had the opposite effect. Mass spectrometry analysis identified several MYPT1-bound synaptosomal proteins, of which interactions of synapsin-I, syntaxin-1, calcineurin-A subunit, and Ca(2+) /calmodulin-dependent kinase II with MYPT1 were confirmed. In intact synaptosomes, TMC increased, whereas Y27632 decreased the phosphorylation levels of MYPT1(Thr696) , myosin-II light chain(Ser19) , synapsin-I(Ser9) , and syntaxin-1(Ser14) , indicating that PP1M and ROK influence their phosphorylation status. Confocal microscopy indicated that MYPT1 and ROK are present in the rat ventral cochlear nucleus both pre- and post-synaptically. Analysis of the neurotransmission in an auditory glutamatergic giant synapse demonstrated that PP1M and ROK affect neurotransmission via both pre- and post-synaptic mechanisms. Our data suggest that both PP1M and ROK influence synaptic transmission, but further studies are needed to give a full account of their mechanism of action.


Subject(s)
Cerebral Cortex/ultrastructure , Exocytosis/physiology , Glutamic Acid/metabolism , Protein Phosphatase 1/metabolism , Synapses/metabolism , Synaptic Transmission/physiology , Synaptosomes/metabolism , rho-Associated Kinases/metabolism , Animals , Animals, Newborn , Calcium/metabolism , Cardiac Myosins/metabolism , Enzyme Inhibitors/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Female , Immunoprecipitation , In Vitro Techniques , Male , Mass Spectrometry , Microscopy, Electron, Transmission , Myosin Light Chains/metabolism , Patch-Clamp Techniques , Phosphorylation , Protein Binding/drug effects , Protein Phosphatase 1/ultrastructure , Qa-SNARE Proteins/metabolism , Rats , Rats, Wistar , Serine/metabolism , Synapses/ultrastructure , Synapsins/metabolism , Synaptosomes/ultrastructure , Threonine/metabolism , rho-Associated Kinases/ultrastructure
12.
Pflugers Arch ; 463(6): 829-44, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22547003

ABSTRACT

Acetylcholine modulates the function of the cochlear nucleus via several pathways. In this study, the effects of cholinergic stimulation were studied on the cytoplasmic Ca(2+) concentration of granule neurones of the rat dorsal cochlear nucleus (DCN). Ca(2+) transients were recorded in Oregon-Green-BAPTA 1-loaded brain slices using a calcium imaging technique. For the detection, identification and characterisation of the Ca(2+) transients, a wavelet analysis-based method was developed. Granule cells were identified on the basis of their size and localisation. The action potential-coupled character of the Ca(2+) transients of the granule cells was established by recording fluorescence changes and electrical activity simultaneously. Application of the cholinergic agonist carbamyl-choline (CCh) significantly increased the frequency of the Ca(2+) transients (from 0.37 to 6.31 min(-1), corresponding to a 17.1-fold increase; n = 89). This effect was antagonised by atropine, whereas CCh could still evoke an 8.3-fold increase of the frequency of the Ca(2+) transients when hexamethonium was present. Using immunolabelling, the expression of both type 1 and type 3 muscarinic receptors (M1 and M3 receptors, respectively) was demonstrated in the granule cells. Application of 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (an M3-specific antagonist) prevented the onset of the CCh effect, whereas an M1-specific antagonist (pirenzepine) was less effective. We conclude that cholinergic stimulation increases the activity of granule cells, mainly by acting on their M3 receptors. The modulation of the firing activity of the granule cells, in turn, may modify the firing of projection neurones and may adjust signal processing in the entire DCN.


Subject(s)
Calcium/metabolism , Cochlear Nucleus/metabolism , Neurons/cytology , Neurons/metabolism , Receptors, Muscarinic/metabolism , Acetylcholine/pharmacology , Action Potentials/drug effects , Animals , Atropine/pharmacology , Carbachol/pharmacology , Cochlear Nucleus/cytology , Female , Male , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Neurons/drug effects , Patch-Clamp Techniques , Pirenzepine/pharmacology , Rats , Rats, Wistar
13.
Brain Res ; 1297: 57-69, 2009 Nov 10.
Article in English | MEDLINE | ID: mdl-19699723

ABSTRACT

Purkinje-like cells (PLCs) of the cochlear nucleus (CN) are strongly calbindin positive neurones with unknown function. In the present work functional and morphological methods have been employed to provide data about PLCs in general, and about their possible involvement in the synaptic organisation of the CN in particular. PLCs had slightly elongated soma, from which a complex dendritic arborisation extended with highly variable dimensions. On the basis of their morphology, three classes of PLCs were identified. Positively identified PLCs fired a train of action potentials on sustained depolarization. When hyperpolarizing stimuli were applied, the presence of a slowly activating, ZD7288-sensitive inward current was noted that corresponded to the h-current. PLCs received both excitatory and inhibitory synaptic inputs. Functional experiments revealed that 76% and 14% of the spontaneous inhibitory postsynaptic currents recorded from the cell bodies of the PLCs were mediated via glycinergic and GABAergic synapses, respectively. PLCs presented strong cerebellin1-like immunoreactivity, but its distribution differed from that seen in cerebellar Purkinje cells. Our results indicate that PLCs are parts of the synaptic circuitry of the CN, thus they may be actively involved in the processing and analysis of auditory information.


Subject(s)
Auditory Pathways/cytology , Auditory Pathways/metabolism , Cochlear Nucleus/cytology , Cochlear Nucleus/metabolism , Neurons/cytology , Neurons/metabolism , Action Potentials/physiology , Animals , Auditory Perception , Calbindins , Cell Shape/physiology , Dendrites/ultrastructure , Electric Stimulation , Excitatory Postsynaptic Potentials/physiology , Female , Fluorescent Antibody Technique , Glutamate Decarboxylase/metabolism , Glycine/metabolism , Inhibitory Postsynaptic Potentials/physiology , Male , Nerve Tissue Proteins/metabolism , Organ Culture Techniques , Patch-Clamp Techniques , Purkinje Cells/cytology , Rats , Rats, Wistar , S100 Calcium Binding Protein G/metabolism , Staining and Labeling , Synaptic Transmission/physiology , gamma-Aminobutyric Acid/metabolism
14.
Hear Res ; 255(1-2): 73-83, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19497356

ABSTRACT

The involvement of astrocytes in the cholinergic modulation of the cochlear nucleus has been studied using primary astrocyte cultures prepared from this nucleus. The cells were loaded with the membrane permeable form of the fluorescent Ca(2+) indicator Fluo-4, and carbachol-induced Ca(2+) concentration increases were monitored using an imaging system. In the presence of cholinergic stimulation 36.3% of the cells produced Ca(2+) transients. The time course of the transients was variable; 45.0% of the responding cells showed only a rapid Ca(2+) concentration increase, while in 50.5% of the astrocytes the fast component was followed by a slow plateau phase. Using muscarine as well as general and more specific cholinergic antagonists (atropine, pirenzepine, 4-DAMP and hexamethonium), the role of the M3 and (to a smaller extent) M1 muscarinic acetylcholine receptors could be demonstrated in the genesis of the carbachol-induced Ca(2+) transients. The presence of these two subtypes of muscarinic receptors has been confirmed at both mRNA (Q-PCR) and protein (immunocytochemistry) levels. Our data demonstrate the responsiveness of the cochlear astrocytes towards cholinergic stimulation, suggesting that they may have roles in mediating the effects of cholinergic modulation in the rat cochlear nucleus.


Subject(s)
Astrocytes/drug effects , Astrocytes/metabolism , Calcium Signaling/drug effects , Cholinergic Agonists/pharmacology , Cochlear Nucleus/drug effects , Cochlear Nucleus/metabolism , Animals , Calcium/metabolism , Calcium Signaling/physiology , Carbachol/pharmacology , Cells, Cultured , Cholinergic Antagonists/pharmacology , Cochlear Nucleus/cytology , Cytoplasm/metabolism , Immunohistochemistry , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Receptor, Muscarinic M1/agonists , Receptor, Muscarinic M1/antagonists & inhibitors , Receptor, Muscarinic M1/genetics , Receptor, Muscarinic M1/metabolism , Receptor, Muscarinic M3/agonists , Receptor, Muscarinic M3/antagonists & inhibitors , Receptor, Muscarinic M3/genetics , Receptor, Muscarinic M3/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...